458 related articles for article (PubMed ID: 35351411)
41. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
Govender N; Naicker T; Rajakumar A; Moodley J
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
[TBL] [Abstract][Full Text] [Related]
42. Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders.
Rana S; Burke SD; Karumanchi SA
Am J Obstet Gynecol; 2022 Feb; 226(2S):S1019-S1034. PubMed ID: 33096092
[TBL] [Abstract][Full Text] [Related]
43. Affinity-Enhanced Multimeric VEGF (Vascular Endothelial Growth Factor) and PlGF (Placental Growth Factor) Variants for Specific Adsorption of sFlt-1 to Restore Angiogenic Balance in Preeclampsia.
Matin M; Mörgelin M; Stetefeld J; Schermer B; Brinkkoetter PT; Benzing T; Koch M; Hagmann H
Hypertension; 2020 Oct; 76(4):1176-1184. PubMed ID: 32623922
[TBL] [Abstract][Full Text] [Related]
44. Cerebral biomarkers in neurologic complications of preeclampsia.
Bergman L; Hastie R; Bokström-Rees E; Zetterberg H; Blennow K; Schell S; Imberg H; Langenegger E; Moodley A; Walker S; Tong S; Cluver C
Am J Obstet Gynecol; 2022 Aug; 227(2):298.e1-298.e10. PubMed ID: 35257666
[TBL] [Abstract][Full Text] [Related]
45. Angiogenic and vasoactive proteins in the maternal-fetal interface in healthy pregnancies and preeclampsia.
Westerberg AC; Degnes ML; Andresen IJ; Roland MCP; Michelsen TM
Am J Obstet Gynecol; 2024 Mar; ():. PubMed ID: 38494070
[TBL] [Abstract][Full Text] [Related]
46. An integrated model of preeclampsia: a multifaceted syndrome of the maternal cardiovascular-placental-fetal array.
Yagel S; Cohen SM; Goldman-Wohl D
Am J Obstet Gynecol; 2022 Feb; 226(2S):S963-S972. PubMed ID: 33712272
[TBL] [Abstract][Full Text] [Related]
47. Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia.
Wang K; Ahmad S; Cai M; Rennie J; Fujisawa T; Crispi F; Baily J; Miller MR; Cudmore M; Hadoke PW; Wang R; Gratacós E; Buhimschi IA; Buhimschi CS; Ahmed A
Circulation; 2013 Jun; 127(25):2514-22. PubMed ID: 23704251
[TBL] [Abstract][Full Text] [Related]
48. Circulating ficolin-2 and ficolin-3 in normal pregnancy and pre-eclampsia.
Halmos A; Rigó J; Szijártó J; Füst G; Prohászka Z; Molvarec A
Clin Exp Immunol; 2012 Jul; 169(1):49-56. PubMed ID: 22670778
[TBL] [Abstract][Full Text] [Related]
49. An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia.
Cim N; Kurdoglu M; Ege S; Yoruk I; Yaman G; Yildizhan R
J Matern Fetal Neonatal Med; 2017 Jul; 30(13):1602-1607. PubMed ID: 27658884
[TBL] [Abstract][Full Text] [Related]
50. Placental trophoblast-specific overexpression of chemerin induces preeclampsia-like symptoms.
Tan L; Chen Z; Sun F; Zhou Z; Zhang B; Wang B; Chen J; Li M; Xiao T; Neuman RI; Niu J; Verdonk K; Lu X; Zhang JV; Danser AHJ; Yang Q; Fan X
Clin Sci (Lond); 2022 Feb; 136(4):257-272. PubMed ID: 35103285
[TBL] [Abstract][Full Text] [Related]
51. Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes.
Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
Am J Obstet Gynecol; 2021 May; 224(5):518.e1-518.e11. PubMed ID: 33166504
[TBL] [Abstract][Full Text] [Related]
52. Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia.
Sandrim VC; Palei AC; Metzger IF; Gomes VA; Cavalli RC; Tanus-Santos JE
Hypertension; 2008 Aug; 52(2):402-7. PubMed ID: 18574068
[TBL] [Abstract][Full Text] [Related]
53. Association between micronutrients, oxidative stress biomarkers and angiogenic growth mediators in early and late-onset preeclamptic Ghanaian women.
Anto EO; Ofori Boadu WI; Addai-Mensah O; Wiafe YA; Owiredu WK; Obirikorang C; Annani-Akollor ME; Adua E; Appiah M; Opoku S; Acheampong E; Asamoah EA; Owiredu EW; Odame Anto A; Tawiah A; Ankobea F; Afrifa Yamoah E; Coall DA
SAGE Open Med; 2023; 11():20503121231175759. PubMed ID: 37324117
[TBL] [Abstract][Full Text] [Related]
54. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
[TBL] [Abstract][Full Text] [Related]
55. [Application of the concetrations ratio of soluble receptor tyrosine kinase type 1, and placental growth factor for short-term prediction and diagnosis of preeclampsia].
Bubeníková Š; Cíchová A; Roubalová L; Durdová V; Vlk R
Ceska Gynekol; 2016; 81(4):272-278. PubMed ID: 27882748
[TBL] [Abstract][Full Text] [Related]
56. Angiogenic Markers and Cardiovascular Indices in the Prediction of Hypertensive Disorders of Pregnancy.
Verlohren S; Perschel FH; Thilaganathan B; Dröge LA; Henrich W; Busjahn A; Khalil A
Hypertension; 2017 Jun; 69(6):1192-1197. PubMed ID: 28461601
[TBL] [Abstract][Full Text] [Related]
57. Preeclampsia in high risk women is characterized by risk group-specific abnormalities in serum biomarkers.
Metz TD; Allshouse AA; Euser AG; Heyborne KD
Am J Obstet Gynecol; 2014 Nov; 211(5):512.e1-6. PubMed ID: 24769011
[TBL] [Abstract][Full Text] [Related]
58. Usefulness of the sFlt-1/PlGF (Soluble fms-Like Tyrosine Kinase-1/Placental Growth Factor) Ratio in Diagnosis or Misdiagnosis in Women With Clinical Diagnosis of Preeclampsia.
Leaños-Miranda A; Graciela Nolasco-Leaños A; Ismael Carrillo-Juárez R; José Molina-Pérez C; Janet Sillas-Pardo L; Manuel Jiménez-Trejo L; Isordia-Salas I; Leticia Ramírez-Valenzuela K
Hypertension; 2020 Sep; 76(3):892-900. PubMed ID: 32713272
[TBL] [Abstract][Full Text] [Related]
59. Placental Growth Factor and Soluble, Fms-Like Tyrosine Kinase-1 in Preeclampsia: A Case-Cohort (PEARL) Study.
Fillion A; Guerby P; Lachance C; Comeau MP; Bussières MC; Doucet-Gingras FA; Zérounian S; Demers S; Laforest G; Menzies D; Bujold E
J Obstet Gynaecol Can; 2020 Oct; 42(10):1235-1242. PubMed ID: 32718871
[TBL] [Abstract][Full Text] [Related]
60. Angiogenic factors in preeclampsia: potential for diagnosis and treatment.
Goel A; Rana S
Curr Opin Nephrol Hypertens; 2013 Nov; 22(6):643-50. PubMed ID: 24076553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
